Shield Therapeutics (STX)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

5.35p
   
  • Change Today:
      0.15p
  • 52 Week High: 12.20p
  • 52 Week Low: 3.73p
  • Currency: UK Pounds
  • Shares Issued: 1,074.16m
  • Volume: 535,128
  • Market Cap: £57.47m
  • Beta: 0.03

STX Overview

Shield is a de-risked commercial stage, pharmaceutical company focused on addressing iron deficiency in adults with or without anaemia. Our clear purpose is to develop products that help patients become people again, enabling them to enjoy the things that make a difference in their everyday lives.

Key Personnel

CEO: Anders Lundstrom
Independent Non-Executive Director: Peter Llewellyn-Davies
Independent Non-Executive Director: Fabiana Lacerca Allen
Non-Executive Chairman: Hans-Peter Hasler
Non-Executive Dir: Christian Schweiger, Rudolf Widmann

Contact Details

Address: Northern Design Centre, Baltic Business Quarter, Gateshead Quays, United Kingdom, NE8 3DF
Phone: +44 (0) 191 511 8500
Website: http://www.shieldtherapeutics.com/

Listings

Sector: Pharma and Biotech(LSE)
Index: FTSE AIM All-Share
ISIN: GB00BYV81293

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

STX Market Data

Currency UK Pounds
Share Price 5.35p
Change Today 0.15p
% Change 2.88 %
52 Week High 12.20p
52 Week Low 3.73p
Volume 535,128
Shares Issued 1,074.16m
Market Cap £57.47m
Beta 0.03

STX Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
8.47% above the market average8.47% above the market average8.47% above the market average8.47% above the market average8.47% above the market average
50% below the sector average50% below the sector average50% below the sector average50% below the sector average50% below the sector average
Price Trend
91.42% above the market average91.42% above the market average91.42% above the market average91.42% above the market average91.42% above the market average
90.70% above the sector average90.70% above the sector average90.70% above the sector average90.70% above the sector average90.70% above the sector average
Income Not Available
Growth
60.84% above the market average60.84% above the market average60.84% above the market average60.84% above the market average60.84% above the market average
78.57% above the sector average78.57% above the sector average78.57% above the sector average78.57% above the sector average78.57% above the sector average

What The Brokers Say

Strong Buy 2
Buy 1
Neutral 0
Sell 0
Strong Sell 0
Total 3
strong_buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

STX Dividends

No dividends found

Trades for 19-Oct-2026

Time Volume / Share Price
14:24 436,003 @ 5.21p
14:23 300 @ 5.20p
14:20 10,000 @ 5.32p
12:47 11,892 @ 5.38p
11:14 19 @ 5.20p

STX Key Personnel

CEO Anders Lundstrom

Top of Page